Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
Frequent activation of phosphatidylinositol-3 kinases (PI3K)/Akt/mTOR signaling pathway in gastric cancer (GC) is gaining immense popularity with identification of mutations and/or amplifications of PIK3CA gene or loss of function of PTEN, a tumor suppressor protein, to name a few; both playing a cr...
Main Authors: | , , , , , , , , |
---|---|
Format: | Journal Article |
Published: |
2015
|
Online Access: | http://hdl.handle.net/20.500.11937/4754 |